Medroxyprogesterone acetate versus ganirelix in oocyte donation: a randomized controlled trial

Medroxyprogesterone acetate is an effective oral alternative for preventing premature luteinizing hormone surges in women undergoing controlled ovarian hyperstimulation for in vitro fertilization

Yanping Kuang, Qiuju Chen, Yonglun Fu et al. · Fertility and Sterility · 2015 · 406 citations · Full text

Medroxyprogesterone Acetate, Hormone Surges, Hormonal Contraceptive +13

Ovarian hyperstimulation syndrome prevention by gonadotropin-releasing hormone agonist triggering of final oocyte maturation in a gonadotropin-releasing hormone antagonist protocol in combination with a “freeze-all” strategy: a prospective multicentric study

Georg Griesinger, Laura Schultz, Thomas Bauer et al. · Fertility and Sterility · 2011 · 184 citations

Fertility, Reproductive Health, Gynecology +17

Triggering with human chorionic gonadotropin or a gonadotropin-releasing hormone agonist in gonadotropin-releasing hormone antagonist-treated oocyte donor cycles: findings of a large retrospective cohort study

Daniel Bodri, Juan José Guillén, Anna Galindo et al. · Fertility and Sterility · 2008 · 123 citations

Oocyte, Infertility, Fertility +11

Interpretation of Plasma Luteinizing Hormone Assay for the Collection of Mature Oocytes from Women: Definition of a Luteinizing Hormone Surge-Initiating Rise

J Testart, René Frydman, Marie Claude Feinstein et al. · Fertility and Sterility · 1981 · 121 citations

Oocyte, Fertility, Reproductive Health +16

The pregnancy outcome of progestin‐primed ovarian stimulation using 4 versus 10 mg of medroxyprogesterone acetate per day in infertile women undergoing <i>in vitro</i> fertilisation: a randomised controlled trial

Jing Dong, You Wang, WR Chai et al. · BJOG An International Journal of Obstetrics & Gynaecology · 2017 · 87 citations